The US Bankruptcy Court gave an order approving the sale of the certain assets of Biocept, Inc. on April 26, 2024. The trustee has been authorized to sell its certain assets to PLUS Therapeutics, Inc. for a purchase price of $0.1 million in cash pursuant to the asset purchase agreement. The debtor?s assets include all of Estate?s right, title and interest of every kind and nature whatsoever of Estate, if any, in and to each piece of equipment located at Sorrento Mesa Self Storage, Unit No.

C1517, 6690 Mira Mesa Blvd., San Diego, CA 92121 excluding cash, deposits, accounts receivable, insurance, rights in insurance, avoidance actions, any rights to and in contracts that are not listed on Schedule 1.1, and other Estate causes of action. Under the terms of the asset purchase agreement, the buyer has made an earnest money deposit of $0.01 million upon the execution of the agreement. The transaction is expected to close on May 15, 2024.

The buyer is represented by Erin N. Brady, and Andrew Strong of Hogan Lovells US LLP as its legal advisors.